China’s New SFDA Chief Has Public Health Background, International Ties
This article was originally published in The Tan Sheet
Executive Summary
Yin Li becomes director of China’s State FDA, taking the reins from Shao Mingli, who led the agency since 2005. Yin’s work as vice minister of health touched on a broad swath of pharmaceutical manufacturing regulation and food safety enforcement.
You may also be interested in...
Executive Decisions Roundup
Hamburg joins IoM as foreign secretary; more people news in brief.
Executive Decisions Roundup
Hamburg joins IoM as foreign secretary; more people news in brief.
China's Center For Drug Evaluation Remakes Itself To Enter New Era Of Transparency, Speed Up Approvals
SHANGHAI - For years, China has talked about revising its drug review system to improve efficiency, and now major changes are in the works with China's State FDA reforming its drug review body, the Center for Drug Evaluation, to encourage drug innovation and facilitate globalization of its drug review process